ATE382349T1 - Antivirale verwendungen von leflunomid produkten - Google Patents

Antivirale verwendungen von leflunomid produkten

Info

Publication number: ATE382349T1
Authority: AT; Austria
Prior art keywords: leflunomide; antiviral uses; products; leflunomide products; antiviral
Prior art date: 1998-03-11

Application number

AT99912426T

Other languages

English (en)

Inventor

James Williams

Anita Chong

W Waldman

Original Assignee

Williams James W

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-11

Publication date

2008-01-15

1999-03-11 Application filed by Williams James W filed Critical Williams James W

2008-01-15 Application granted granted Critical

2008-01-15 Publication of ATE382349T1 publication Critical patent/ATE382349T1/de

Links

230000000840 anti-viral effect Effects 0.000 title abstract 2
VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 title abstract 2
229960000681 leflunomide Drugs 0.000 title abstract 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 abstract 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 abstract 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 abstract 1
229940045145 uridine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Saccharide Compounds (AREA)

AT99912426T 1998-03-11 1999-03-11 Antivirale verwendungen von leflunomid produkten ATE382349T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7755298P	1998-03-11	1998-03-11

Publications (1)

Publication Number	Publication Date
ATE382349T1 true ATE382349T1 (de)	2008-01-15

Family

ID=22138741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99912426T ATE382349T1 (de)	1998-03-11	1999-03-11	Antivirale verwendungen von leflunomid produkten

Country Status (7)

Country	Link
EP (1)	EP1169036B1 (de)
JP (1)	JP4581137B2 (de)
AT (1)	ATE382349T1 (de)
AU (1)	AU3080299A (de)
DE (1)	DE69937904T2 (de)
HK (1)	HK1045251A1 (de)
WO (1)	WO1999045908A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003526639A (ja) *	2000-02-28	2003-09-09	バイエルアクチェンゲゼルシャフト	ウイルス疾患のための薬物
JP2005104852A (ja) *	2003-09-29	2005-04-21	Kyowa Hakko Kogyo Co Ltd	モービリウィルス感染症の予防または治療用組成物
US20060024376A1 (en) *	2004-07-30	2006-02-02	The University Of Chicago	Methods and compositions for reducing toxicity associated with leflunomide treatment
WO2021164672A1 (zh) *	2020-02-18	2021-08-26	华东理工大学	抗rna病毒药物及其应用
CA3207366A1 (fr) *	2021-02-10	2022-08-18	Henry JOSEPH	Composition therapeutique a base de feuilles de neurolaena inhibitrice de la dhodh pour le traitement d'infections par virus a arn
FR3119539B1 (fr) *	2021-02-10	2023-12-22	Phytobokaz	Composition thérapeutique inhibitrice de la DHODH

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES448386A1 (es) *	1975-06-05	1978-04-16	Hoechst Ag	Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
ES2124801T3 (es) *	1993-01-08	1999-02-16	Hoechst Ag	Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
ES2124800T3 (es) *	1993-01-08	1999-02-16	Hoechst Ag	Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
WO1994024095A1 (en) *	1993-04-16	1994-10-27	Abbott Laboratories	Immunosuppressive agents
US5519042A (en) *	1994-01-13	1996-05-21	Hoechst Aktiengesellschaft	Method of treating hyperproliferative vascular disease
JP4408450B2 (ja) *	1994-07-01	2010-02-03	ウェルスタットセラピューティクスコーポレイション	全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体
DE19711800A1 (de) *	1997-03-21	1998-09-24	Hoechst Ag	Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung

1999
- 1999-03-11 EP EP99912426A patent/EP1169036B1/de not_active Expired - Lifetime
- 1999-03-11 AT AT99912426T patent/ATE382349T1/de not_active IP Right Cessation
- 1999-03-11 JP JP2000535323A patent/JP4581137B2/ja not_active Expired - Fee Related
- 1999-03-11 AU AU30802/99A patent/AU3080299A/en not_active Abandoned
- 1999-03-11 WO PCT/US1999/005326 patent/WO1999045908A2/en not_active Ceased
- 1999-03-11 HK HK02105067.5A patent/HK1045251A1/zh unknown
- 1999-03-11 DE DE69937904T patent/DE69937904T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4581137B2 (ja)	2010-11-17
EP1169036B1 (de)	2008-01-02
AU3080299A (en)	1999-09-27
WO1999045908A3 (en)	2000-01-20
JP2003523309A (ja)	2003-08-05
HK1045251A1 (zh)	2002-11-22
EP1169036A2 (de)	2002-01-09
DE69937904D1 (de)	2008-02-14
DE69937904T2 (de)	2009-01-02
WO1999045908A2 (en)	1999-09-16

Legal Events

Date	Code	Title	Description
2008-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
CA2444439A1 (en)	2002-12-05	Disposable absorbent articles contained in package having window
BR9807742A (pt)	2000-02-22	EpotilÈneos que são modificados na cadeia lateral
FI940027A7 (fi)	1994-01-04	Parannuksia itse varjoaineisiin tai parannuksia, jotka liittyvät niihi n
GB0011203D0 (en)	2000-06-28	Chemical compounds
WO2001060157A3 (en)	2002-01-24	Antibacterial agents and compositions
DE69937904D1 (de)	2008-02-14	Antivirale verwendungen von leflunomid produkten
ATE362384T1 (de)	2007-06-15	Kosmetische zusammensetzungen
MXPA03009868A (es)	2004-05-24	Composiciones de recubrimiento que comprenden productos de carbon de area-t alta.
CA97856S (en)	2003-02-18	Bottle
TR200003203T2 (tr)	2001-03-21	Karboksaldehitin saflaştırılması
DE59606611D1 (de)	2001-04-26	Lagerstabile, konzentrierte Tensidzusammensetzung auf der Basis von Alkylglucosiden
ATE213236T1 (de)	2002-02-15	Substituierte benzyloxyimino-verbindungen
DE59912720D1 (de)	2005-12-01	Sonnenschutzmittel mit mikropartikeln auf basis von wasserunlöslichem linearem polyglucan
ATE431304T1 (de)	2009-05-15	Artikelträger und zuschnitt
BR8001117U (pt)	2001-11-27	Painéis murais em aço
NO960849D0 (no)	1996-03-01	Difluorstaton-antivirale analoger
DE69937148D1 (de)	2007-10-31	Varianten der glukoamylase
TH54346S (th)	2002-12-12	ถาด
TH16547S1 (th)	2004-03-31	ถาด
IT1299263B1 (it)	2000-02-29	5-aril-4-isossazolcarbonitrili 3 sostituiti ad attivita' antivirale
TH42456S (th)	2001-01-17	ปากกา
TH37039S (th)	2000-01-31	ลวดลายของเสื้อ
TH43551S (th)	2001-03-07	หน้าตัดชิ้นส่วนวงกบ
IT1269457B (it)	1997-04-01	Forno periodico
TH67002S (th)	2005-02-04	บัลลาสต์